Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zevra Therapeutics, Inc. - Common Stock (NQ:ZVRA)

8.993 -0.012 (-0.13%)
Streaming Delayed Price Updated: 9:30 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,606
Open 8.993
Bid (Size) 8.960 (2)
Ask (Size) 9.000 (46)
Prev. Close 9.005
Today's Range 8.990 - 9.020
52wk Range 6.190 - 13.16
Shares Outstanding 33,932,639
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Crude Oil Down 1%; Performance Food Group Earnings Top Views
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
+2.7%
+2.7%
1 Month
-23.3%
-23.3%
3 Month
+4.5%
+4.5%
6 Month
+13.1%
+13.1%
1 Year
+27.0%
+27.0%

More News

Read More
Top movers in Wednesday's session
Via Chartmill
Zevra Reported Its First-Ever Quarterly Profit. Why Shares Of The Top 6% Stock Crashed.
Via Investor's Business Daily
A Look at Zevra Therapeutics's Upcoming Earnings Report
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss Zevra Therapeutics Stock
Via Benzinga
Wednesday's session: gap up and gap down stocks
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Zevra Revenue Jumps 486 Percent in Q2
Via The Motley Fool
Topics Intellectual Property
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For August 12, 2025
Via Benzinga
How Zevra's Miplyffa Could Transform Investment Strategies
Via Benzinga
This Block Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Breaking Down Zevra Therapeutics: 6 Analysts Share Their Views
Via Benzinga
Zevra Therapeutics (ZVRA) Stock Jumps on Strong Q1 Results: What's Going On?
Via Benzinga
Zevra Therapeutics's Earnings Outlook
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead
Via Stocktwits
Topics Stocks
Zevra Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Earnings Scheduled For March 11, 2025
Via Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Via Investor's Business Daily
Topics Artificial Intelligence Government
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Frequently Asked Questions

Is Zevra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Zevra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Zevra Therapeutics, Inc. - Common Stock trade on?
Zevra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Zevra Therapeutics, Inc. - Common Stock?
The ticker symbol for Zevra Therapeutics, Inc. - Common Stock is ZVRA on the Nasdaq Stock Market
What is the current price of Zevra Therapeutics, Inc. - Common Stock?
The current price of Zevra Therapeutics, Inc. - Common Stock is 8.993
When was Zevra Therapeutics, Inc. - Common Stock last traded?
The last trade of Zevra Therapeutics, Inc. - Common Stock was at 08/20/25 09:30 AM ET
What is the market capitalization of Zevra Therapeutics, Inc. - Common Stock?
The market capitalization of Zevra Therapeutics, Inc. - Common Stock is 305.17M
How many shares of Zevra Therapeutics, Inc. - Common Stock are outstanding?
Zevra Therapeutics, Inc. - Common Stock has 305M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.